Istodax (romidepsin) – Restricted Access Program

ISTODAX (romidepsin), a cancer medication, has been withdrawn from the Canadian market due to new safety information. The withdrawal affects all ISTODAX products distributed across Canada. Patients currently using this medication should contact their healthcare provider for guidance.

Product

ISTODAX (romidepsin)

Reason

New safety information - Product withdrawal

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2023-03-20

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/32e64e74-9774-4be9-9235-5bf90ecc97c8